Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02148432Completed
Randomised trial of dexmedetomidine in sleep apnea syndrome (SAS) (2 arms), sponsored by Yonsei University. Primary endpoint: Desaturation rate. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02148432.